+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

Journal of Clinical Pharmacology 44(6): 559-569

Serious drug-drug interactions have contributed to recent U.S. market withdrawals and also recent nonapprovals of a few new molecular entities. Many of these interactions involved the inhibition or induction of metabolizing enzymes and efflux transporters, resulting in altered systemic exposure and adverse drug reactions or loss of efficacy. In addition to drug-drug interactions, drug-dietary supplement and drug-citrus fruit interactions, among others, could also cause adverse drug reactions or loss of efficacy and are important issues to consider in the evaluation of new drug candidates. This commentary reviews (1). the current understanding of the mechanistic basis of these interactions, (2). issues to consider in the interpretation of study results, and (3). recent labeling examples to illustrate the translation of study results to information useful for patients and health care providers.

(PDF emailed within 0-6 h: $19.90)

Accession: 011978923

Download citation: RISBibTeXText

PMID: 15145962

DOI: 10.1177/0091270004265367

Related references

Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications. Journal of Alternative and Complementary Medicine 8(3): 293-308, 2002

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study. Frontiers in Pharmacology 10: 265, 2019

Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. Journal of Food Science 76(4): R112-R124, 2012

Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4. Clinical Pharmacokinetics 45(10): 1035-1050, 2006

In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development. Current Topics in Medicinal Chemistry 14(11): 1325-1338, 2015

Addressing drug-drug and drug-food interactions through personalized empowerment services for healthcare. Conference Proceedings 2016: 5640-5643, 2017

Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide. Clinical Pharmacokinetics 46(2): 93-108, 2007

Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers. Clinical Calcium 15(10): 1709-1716, 2005

Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions. Journal of Medicinal Food 14(1-2): 135-139, 2011

Mechanisms and Clinical Significance of Pharmacokinetic-based Drug-drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Drug Metabolism and Disposition: the Biological Fate of Chemicals 2018, 2018

Supplement 1: HIV Prevention with Drug-Using Populations: Current Status and Future Prospects || Fifteen Years of Research on Preventing HIV Infection among Injecting Drug Users: What We Have Learned, What We Have Not Learned, What We Have Done, What We Have Not Done. Public Health Reports 113: 182-188, 1998

Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016. Drug Metabolism and Disposition: the Biological Fate of Chemicals 46(6): 835-845, 2018

Deep learning improves prediction of drug-drug and drug-food interactions. Proceedings of the National Academy of Sciences of the United States of America 115(18): E4304-E4311, 2018

Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine. Journal of Clinical Pharmacology 45(12): 1360-1367, 2005

11th annual conference of the usa food and drug administration and drug law institute on food and drug contaminants and related problems arlington virginia usa november 27 1967 symposium microorganism drug quality. Medical Annals Of The District Of Columbia: 131, 1968